Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    March 2018
  1. KAPLAN DE
    Cost/Benefit of Hepatitis C Treatment: It Does Not End with SVR.
    Dig Dis Sci. 2018 Mar 17. pii: 10.1007/s10620-018-5014.
    PubMed     Text format    


  2. ABDEL-MONEIM A, Aboud A, Abdel-Gabbar M, Zanaty M, et al
    Retreatment Efficacy of Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir + Ribavirin for Hepatitis C Virus Genotype 4 Patients.
    Dig Dis Sci. 2018 Mar 15. pii: 10.1007/s10620-018-5005.
    PubMed     Text format     Abstract available


  3. HU KQ, Cui W
    Persistence of Circulating Hepatitis C Virus Antigens-Specific Immune Complexes in Patients with Resolved HCV Infection.
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-4968.
    PubMed     Text format     Abstract available


    February 2018
  4. TANEJA S, Duseja A, De A, Mehta M, et al
    Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4979.
    PubMed     Text format     Abstract available


  5. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    PubMed     Text format     Abstract available


    January 2018
  6. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
    Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
    PubMed     Text format     Abstract available


  7. ABDEL-HAMEED EA, Rouster SD, Boyce CL, Zhang X, et al
    Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4895.
    PubMed     Text format     Abstract available


    December 2017
  8. HOVAIDA M, Torrazza-Perez E, McCarthy D
    Liver Function Tests "Gone Viral": Acute Hepatitis of Uncertain Cause.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4849.
    PubMed     Text format    


    November 2017
  9. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Text format     Abstract available


    October 2017
  10. BOSCARINO JA, Moorman AC, Rupp LB, Zhou Y, et al
    Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution.
    Dig Dis Sci. 2017;62:2704-2712.
    PubMed     Text format     Abstract available


    September 2017
  11. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
    A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
    PubMed     Text format     Abstract available


  12. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    PubMed     Text format     Abstract available


  13. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
    Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
    PubMed     Text format     Abstract available


  14. CHAN J, Gogela N, Zheng H, Lammert S, et al
    Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment.
    Dig Dis Sci. 2017 Sep 8. doi: 10.1007/s10620-017-4749.
    PubMed     Text format     Abstract available


  15. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
    Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
    PubMed     Text format     Abstract available


    August 2017
  16. YAYA I, Roux P, Marcellin F, Salmon-Ceron D, et al
    Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4703.
    PubMed     Text format    


    June 2017
  17. AFSARI A, Lee E, Shokrani B, Boortalary T, et al
    Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Jun 13. doi: 10.1007/s10620-017-4626.
    PubMed     Text format     Abstract available


  18. WU E, Yang M, Rao H, Fu S, et al
    Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China.
    Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4619.
    PubMed     Text format     Abstract available


    May 2017
  19. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Text format     Abstract available


  20. LENCI I, Bosa A, Milana M, Baiocchi L, et al
    Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation.
    Dig Dis Sci. 2017 May 12. doi: 10.1007/s10620-017-4594.
    PubMed     Text format    


    April 2017
  21. DEVER JB, Ducom JH, Ma A, Nguyen J, et al
    Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.
    Dig Dis Sci. 2017 Apr 4. doi: 10.1007/s10620-017-4548.
    PubMed     Text format     Abstract available


    February 2017
  22. AHN J, Liu B, Bhuket T, Wong RJ, et al
    Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Dig Dis Sci. 2017 Feb 6. doi: 10.1007/s10620-017-4469.
    PubMed     Text format     Abstract available


    January 2017
  23. AGORAMOORTHY G
    India Needs Effective Surveillance to Control Hepatitis C.
    Dig Dis Sci. 2017 Jan 3. doi: 10.1007/s10620-016-4436.
    PubMed     Text format    


  24. DELLA-GUARDIA B, Evangelista AS, Felga GE, Marins LV, et al
    Diagnostic Accuracy of Transient Elastography for Detecting Liver Fibrosis After Liver Trannsplantation: A Specific Cut-Off Value Is Really Needed?
    Dig Dis Sci. 2017;62:264-272.
    PubMed     Text format     Abstract available


    October 2016
  25. BECK KR, Kim N, Khalili M
    Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    September 2016
  26. NATARAJAN Y, White DL, El-Serag HB, Ramsey D, et al
    Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  27. HE QF, Zhang QF, Zhang DZ
    Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  28. FOX R
    Going Viral: Why Eliminating the Burden of Hepatitis C Requires Enhanced Cooperation Between Specialists and Primary Care Providers.
    Dig Dis Sci. 2016.
    PubMed     Text format    


    August 2016
  29. FOSTER MA, Xing J, Moorman AC, Boscarino J, et al
    Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    May 2016
  30. CHAK EW, Sarkar S, Bowlus C
    Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  31. MOORMAN AC, Tong X, Spradling PR, Rupp LB, et al
    Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS).
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    April 2016
  32. CHOLANKERIL G, Perumpail RB, Hu M, Skowron G, et al
    Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  33. COZEN ML, Ryan JC, Shen H, Cheung R, et al
    Improved Survival Among all Interferon-alpha-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  34. JHA LK, Gilbert J
    Treatment of Dual Genotype Chronic Hepatitis C: Case Series.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  35. PECTASIDES E, Miksad R, Pyatibrat S, Srivastava A, et al
    Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    March 2016
  36. BURMAN BE, Bacchetti P, Khalili M
    Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C Infection.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  37. THOMSON M, Konerman MA, Choxi H, Lok AS, et al
    Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    January 2016
  38. FLEMMING JA, Saxena V, Shen H, Terrault NA, et al
    Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.
    Dig Dis Sci. 2016;61:62-9.
    PubMed     Text format     Abstract available


    December 2015
  39. DYAL HK, Aguilar M, Bartos G, Holt EW, et al
    Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    November 2015
  40. ROGAL SS, Yan P, Rimland D, Re VL 3rd, et al
    Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    October 2015
  41. JAYASEKERA CR, Perumpail RB, Chao DT, Pham EA, et al
    Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  42. GARCIA-COMPEAN D, Gonzalez-Gonzalez JA, Lavalle-Gonzalez FJ, Gonzalez-Moreno EI, et al
    Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    September 2015
  43. GOLDHABER-FIEBERT JD
    New, Expensive Treatments for Chronic Hepatitis C: Insuring Good Outcomes?
    Dig Dis Sci. 2015.
    PubMed     Text format    


    August 2015
  44. COLOM STEELE D, Mojtahed A, Samedi V, Alcorn J, et al
    "Ferritin Out" a Cause of Acute Hepatitis.
    Dig Dis Sci. 2015.
    PubMed     Text format    


    July 2015
  45. MEILLIER A, Patel S, Al-Osaimi AM
    Readability of Healthcare Literature for Hepatitis B and C.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  46. FABRIZI F, Verdesca S, Messa P, Martin P, et al
    Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  47. DYAL HK, Aguilar M, Bhuket T, Liu B, et al
    Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    June 2015
  48. CASADO JL, Esteban MA, Banon S, Moreno A, et al
    Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  49. PERUMPAIL RB, Wong RJ, Pham EA, Higgins JP, et al
    A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  50. FEENEY ER, Chung RT
    The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C.
    Dig Dis Sci. 2015.
    PubMed     Text format    


    May 2015
  51. SAAB S, Rheem J, Sundaram V
    Hepatitis C Infection in the Elderly.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  52. STEPANOVA M, Younossi ZM
    Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    November 2014
  53. ROGAL SS, Bielefeldt K, Wasan AD, Szigethy E, et al
    Fibromyalgia Symptoms and Cirrhosis.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


  54. STINE JG, Intagliata N, Shah NL, Argo CK, et al
    Hepatic Decompensation Likely Attributable to Simeprevir in Patients with Advanced Cirrhosis.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: